125 related articles for article (PubMed ID: 18329610)
21. An in vitro antituberculosis drug sensitivity of isolates of Mycobacterium tuberculosis from human cases of pulmonary tuberculosis.
Shah VM; Jhala CI
J Indian Med Assoc; 1976 Aug; 67(3):57-9. PubMed ID: 828192
[No Abstract] [Full Text] [Related]
22. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
Tsukamura M
Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
[No Abstract] [Full Text] [Related]
23. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
[TBL] [Abstract][Full Text] [Related]
24. A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.
Schaaf K; Hayley V; Speer A; Wolschendorf F; Niederweis M; Kutsch O; Sun J
Assay Drug Dev Technol; 2016 Aug; 14(6):345-54. PubMed ID: 27327048
[TBL] [Abstract][Full Text] [Related]
25. Biflavonoids as novel antituberculosis agents.
Lin YM; Flavin MT; Cassidy CS; Mar A; Chen FC
Bioorg Med Chem Lett; 2001 Aug; 11(16):2101-4. PubMed ID: 11514148
[TBL] [Abstract][Full Text] [Related]
26. SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
Reddy VM; Dubuisson T; Einck L; Wallis RS; Jakubiec W; Ladukto L; Campbell S; Nacy CA
J Antimicrob Chemother; 2012 May; 67(5):1163-6. PubMed ID: 22258923
[TBL] [Abstract][Full Text] [Related]
27. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
[TBL] [Abstract][Full Text] [Related]
28. Development of efflux pump inhibitors in antituberculosis therapy.
Song L; Wu X
Int J Antimicrob Agents; 2016 Jun; 47(6):421-9. PubMed ID: 27211826
[TBL] [Abstract][Full Text] [Related]
29. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
[TBL] [Abstract][Full Text] [Related]
30. Primary drug resistance of Mycobacterium tuberculosis to antituberculosis drugs.
Safi MI; Zai S
J Pak Med Assoc; 1988 Mar; 38(3):73-4. PubMed ID: 3133501
[No Abstract] [Full Text] [Related]
31. Effect of Mycobacterium tuberculosis Enhancement of Macrophage P-Glycoprotein Expression and Activity on Intracellular Survival During Antituberculosis Drug Treatment.
Wu Q; Hossfeld A; Gerberick A; Saljoughian N; Tiwari C; Mehra S; Ganesan LP; Wozniak DJ; Rajaram MVS
J Infect Dis; 2019 Nov; 220(12):1989-1998. PubMed ID: 31412123
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB
Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172
[TBL] [Abstract]
